Glioma
📧 Sign up to get email alerts when something new happens for Glioma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Step Count Monitoring as a Measure of Physical Activity in Patients With Newly Diagnosed Glioma Undergoing Radiation Therapy [NA]
This clinical trial update describes evaluating step count monitoring as a measure of physical activity in patients with newly diagnosed gli…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Simulation-Based Caregiving Skills Training for Family Members of High Grade Glioma Patients [NA]
Clinical trial update for a simulation-based caregiving skills training program for family members of patients with high-grade glioma, curre…
-
CLINICAL_TRIALS trial_result · 2026-02-18Clinical Trial Update: Quality of Life and Cognitive Functioning in Patients With Glial Tumors [NA]
A clinical trial evaluating quality of life and cognitive functioning in patients with glial tumors has completed.
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: Study of AG-120 and AG-881 in Subjects With Low Grade Glioma [Phase 1]
The study reports the completion of a Phase 1 trial evaluating AG-120 (ivosidenib) and AG-881 (vorasidenib) in subjects with low-grade gliom…
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: Study of Orally Administered AG-120 in Subjects With Advanced Solid Tumors, Including Glioma, With an IDH1 Mutation [Phase 1]
Phase 1 study of AG-120 (ivosidenib) for IDH1-mutant advanced solid tumors, including glioma, has completed enrollment and data collection.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Study of Orally Administered AG-881 in Patients With Advanced Solid Tumors, Including Gliomas, With an IDH1 and/or IDH2 Mutation [Phase 1]
A Phase 1 study evaluating orally administered AG-881 in patients with advanced solid tumors, including gliomas with IDH1 or IDH2 mutations;…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Analysis of Cerebrospinal Fluid Leakage After Surgery for Intracranial Tumors
This clinical trial update indicates the study analyzing cerebrospinal fluid leakage after intracranial tumor surgery is currently recruitin…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Feasibility of Intraoperative Microdialysis During Neurosurgery for Central Nervous System Malignancies [NA]
This clinical trial update notes a Mayo Clinic-sponsored feasibility study on intraoperative microdialysis during neurosurgery for central n…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Niraparib In Recurrent IDH 1/2 Gliomas [EARLY_Phase 1]
An early-phase 1 trial update evaluating niraparib in recurrent IDH1/2-mutant gliomas, including low-grade and malignant gliomas.
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating Panitumumab-IRDye800 for fluorescence-guided diagnosis in patients with malignant glioma undergoing su…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Evaluation of the CONVIVO System [NA]
The CONVIVO System is currently recruiting for a clinical trial evaluating its use in brain tumor surgery. It targets glioblastoma, glioma, …
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectable Brain Tumors [Phase 1]
A Phase 1 imaging trial evaluating a zirconium-89 labeled antibody (Zr-89 Crefmirlimab Berdoxam) for Immuno-PET imaging of resectable brain …
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Contrast Enhanced Ultrasound in Neurosurgery to Improve Glioma Visualization and Border Demarcation [EARLY_Phase 1]
Early-phase clinical trial evaluating contrast-enhanced ultrasound to improve visualization and border demarcation of glioma during neurosur…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: CARv3-TEAM-E T Cells in Glioblastoma [Phase 1]
A Phase 1 clinical trial evaluating CARv3-TEAM-E T cells for glioblastoma and malignant glioma is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: Memory-Enriched T Cells in Treating Patients With Recurrent or Refractory Grade III-IV Glioma [Phase 1]
This is a Phase 1 clinical trial evaluating memory-enriched T cells for recurrent or refractory Grade III-IV glioma, including glioblastoma …
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Study of DS-1001b in Patients With Gene IDH1-Mutated Gliomas [Phase 1]
A Phase 1 study of DS-1001b in patients with IDH1-mutated gliomas is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Use of CEST (Chemical Exchange Saturation Transfer) Imaging in PET/MRI [NA]
This clinical trial update describes the use of Chemical Exchange Saturation Transfer (CEST) imaging in PET/MRI for glioma and brain metasta…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Cognitive Changes of IDH-mutant and IDH-wildtype Glioma Patients After Chemoradiotherapy With Radiation Dose to the Resting State Networks
This clinical trial is recruiting glioma patients with IDH-mutant and IDH-wildtype status to study cognitive changes after chemoradiotherapy…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Amino Acid Transporter System PET/CT Imaging in AATS-Related Diseases
Ongoing clinical trial evaluating PET/CT imaging of the amino acid transporter system (AATS) in AATS-related diseases; currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-01-27Clinical Trial Update: Tumor Hypoxia and Proliferation in Patients With High-Grade Glioma [Phase 1]
Phase 1 trial evaluating tumor hypoxia and proliferation in high-grade glioma has been suspended. Sponsor: Weill Medical College of Cornell …
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: Sequential Treatments or Combinations Including Dasatinib, Quercetin, Fisetin and/or Temozolomide for the Treatment of Previously Treated Glioma With Residual Disease [EARLY_Phase 1]
EARLY_PHASE1 Mayo Clinic trial evaluating sequences or combinations of dasatinib, quercetin, fisetin and/or temozolomide for previously trea…
-
CLINICAL_TRIALS trial_result · 2026-01-26Clinical Trial Update: Leica Microsystems Sponsored PMCF Study to Collect and Confirm Clinical Data on the Performance of the GLOW400 Device When Used in Accordance With Its Intended Use
Leica Microsystems has initiated a post-market clinical follow-up study to collect data on the performance of the GLOW400 device when used a…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: LITT Followed by Hypofractionated RT for Recurrent Gliomas [NA]
Clinical trial evaluating laser interstitial thermal therapy (LITT) followed by hypofractionated radiation therapy for recurrent gliomas; re…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: IL13Rα2 CAR-T for Patients With r/r Glioma [Phase 1]
Phase 1 trial of IL13Rα2-targeted CAR-T therapy for recurrent or relapsed glioma; the study status is suspended.
-
CLINICAL_TRIALS trial_result · 2026-01-15Clinical Trial Update: fMRI Reveal Functional Preservation in Glioma Peritumoral Edema
A completed clinical trial reports that functional MRI demonstrates preserved function in glioma peritumoral edema.